Rocket Pharmaceuticals (RCKT) Return on Assets Growth (5y) (2020 - 2026)
Rocket Pharmaceuticals (RCKT) Return on Assets Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Rocket Pharmaceuticals | 369.48 Mn | 369.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 657.00 |
| Dec 31, 2025 | 136.00 |
| Sep 30, 2025 | 97.00 |
| Jun 30, 2025 | 115.00 |
| Mar 31, 2025 | 91.00 |
| Dec 31, 2024 | 89.00 |
| Sep 30, 2024 | 177.00 |
| Jun 30, 2024 | 179.00 |
| Dec 31, 2022 | -1.00 |
| Sep 30, 2022 | -412.00 |
| Jun 30, 2022 | -539.00 |
| Mar 31, 2022 | -680.00 |
| Dec 31, 2021 | -1,146.00 |
| Sep 30, 2021 | -853.00 |
| Jun 30, 2021 | -987.00 |
| Mar 31, 2021 | -657.00 |
| Dec 31, 2020 | -137.00 |
| Sep 30, 2020 | -97.00 |
| Jun 30, 2020 | -116.00 |
| Mar 31, 2020 | -91.00 |